Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Peter, Doshi"'
Autor:
Florence Bourgeois, Peter Doshi, Kyungwan Hong, Tom Jefferson, Mark Jones, Haeyoung Lee, Anisa Rowhani-Farid, Larissa Shamseer, O’Mareen Spence
Publikováno v:
mSphere, Vol 5, Iss 6 (2020)
Externí odkaz:
https://doaj.org/article/bbd71c70e491469e9b2e758d9cde53e4
Autor:
Alex Hodkinson, Kristina Charlotte Dietz, Carol Lefebvre, Su Golder, Mark Jones, Peter Doshi, Carl Heneghan, Tom Jefferson, Isabelle Boutron, Lesley Stewart
Publikováno v:
Systematic Reviews, Vol 7, Iss 1, Pp 1-12 (2018)
Abstract Background Clinical study reports (CSRs) are produced for marketing authorisation applications. They often contain considerably more information about, and data from, clinical trials than corresponding journal publications. Use of data from
Externí odkaz:
https://doaj.org/article/80615f9e14c4416d80bb7335cdb1879f
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-5 (2018)
Abstract Background Participants are recruited into clinical trials under the assumption that the research will contribute to medical knowledge. Therefore, non-publication trials—and, more recently, lack of data sharing—are widely considered to v
Externí odkaz:
https://doaj.org/article/0553c542d0464aab859ecf03f21847c9
Publikováno v:
Journal of Evaluation in Clinical Practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a763370fa6d154f3044381dcd230176e
https://doi.org/10.1111/jep.13839
https://doi.org/10.1111/jep.13839
Publikováno v:
BMJ Evidence-Based Medicine. 27:199-205
Summary box Access to data for drugs and vaccines has historically been fairly limited to journal article publications and hard-to-access and difficult to read regulatory reports.1 But the past decade has witnessed strides in clinical trial data tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2118e5c2b76f66c63c92fbf5f36306ed
https://doi.org/10.1136/bmjebm-2021-111735
https://doi.org/10.1136/bmjebm-2021-111735
Publikováno v:
Clinical Trials. :174077452311677
Background/Aims: Inadequate description of trial interventions in publications has been repeatedly reported, a problem that extends to the description of placebo controls. Without describing placebo contents, it cannot be assumed that a placebo is in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::697fbade4092d808894500e8e65a0db7
https://doi.org/10.1177/17407745231167756
https://doi.org/10.1177/17407745231167756
Autor:
Joseph Fraiman, Juan Erviti, Mark Jones, Sander Greenland, Patrick Whelan, Robert M. Kaplan, Peter Doshi
Publikováno v:
Vaccine. 40(40)
In 2020, prior to COVID-19 vaccine rollout, the Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We adapted the Brighton Collaboration list to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf0a9f29c6e8437a88d2d590fb4ffd5f
https://pubmed.ncbi.nlm.nih.gov/36055877
https://pubmed.ncbi.nlm.nih.gov/36055877
Autor:
Carl J Heneghan, Igho Onakpoya, Mark A Jones, Peter Doshi, Chris B Del Mar, Rokuro Hama, Matthew J Thompson, Elizabeth A Spencer, Kamal R Mahtani, David Nunan, Jeremy Howick, Tom Jefferson
Publikováno v:
Health Technology Assessment, Vol 20, Iss 42 (2016)
Background: Neuraminidase inhibitors (NIs) are stockpiled and recommended by public health agencies for treating and preventing seasonal and pandemic influenza. They are used clinically worldwide. Objectives: To (1) describe the potential benefits an
Externí odkaz:
https://doaj.org/article/5a69eccc212d4aecb10cd309f4bfe7af
Autor:
Kyungwan Hong, Peter Doshi, Mark Jones, Florence T. Bourgeois, Larissa Shamseer, O'Mareen Spence, Haeyoung Lee, Tom Jefferson
Publikováno v:
BMJ Evidence-Based Medicine
PurposeTrustworthy reporting of quadrivalent human papillomavirus (HPV) vaccine trials is the foundation for assessing the vaccine’s risks and benefits. However, several pivotal trial publications incompletely reported important methodological deta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f1c64cd151f595ad7e1f38e4e89933
https://doi.org/10.1136/bmjebm-2019-111331
https://doi.org/10.1136/bmjebm-2019-111331